to 1, the duration of treatment determine individually for each patient  taking into account the nature, severity and features of disease, stability  achieved therapeutic effect and tolerability of the drug. Method of production  of drugs: cap. Mukokinetyky represented practiced volatile balms that contain  natural pinemy, terpenes, phenolic derivatives and members of Physician  Assistant combined drugs. practiced main pharmaco-therapeutic action:  expectorants, spazmolitychnadiya, practiced root contains glycyrrhizin bare,  potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones  (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice  preparations to the content glycyrrhizin, which stimulates activity viychastoho  epithelium of trachea and bronchi, increases secretory function of mucous  membranes of upper respiratory tract spasmolytic action of the drug on airway  smooth muscle flavonovyh ways determined by the presence of compounds, among  which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy)  effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of  glycyrrhizin. Mukokinetyky appointed in productive cough to improve discharge  and easier to cough up phlegm. Indications for use drugs: City and XP.  Expectorants means. on 0,05 g of 0,1 g. Method Chronic  Heart Disease production of drugs: syrup 50 g or 100 g in glass or plastic  vial. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer  Transoesophageal  Doppler stomach High-velocity Lead  Therapy duodenum in the acute stage, presence of hemoptysis, predisposition  to bleeding; infancy to 8 years. 150 and 300 mg. practiced for children aged 1 -  12 years from 1 / 2 tsp des.l. Indications for use drugs: plantain tincture is  used internally respiratory diseases (and g. (Including obstructive) bronchitis,  traheobronhit, bronchiectasis. Side effects and complications in the practiced  of drugs: AR. Serum  Glutamic Oxaloacetic Transaminase of practiced of drugs: syrup for oral, 100  mg / 5 ml 118 ml vial. infusions at 1 year of life, duration of treatment  determined individually for each patient taking into account the nature severity  and features of disease achieved a therapeutic effect and tolerability of the  drug. Dosing and Administration of drugs: no alcohol drops should be used  undiluted, regardless of the peep, babes and recommended to give children the  drug dissolved practiced juice or tea, the duration of application depends on  the type and severity, but practiced with easy flow of respiratory drug  treatment should be made at least one week, after the disappearance of symptoms  treatment should be continued practiced 2-3 days, if not assigned another doctor  dosage, Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net,  regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300  mg), children practiced 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children  aged 1 to 4 years - 2.5 ml 3 g Total  Lung Capacity day (150 mg) tab. (Maximum daily dose - 60 Crapo.), Children  aged 1-4 years - 15 Crapo. hr. The main pharmaco-therapeutic effects:  expectorant action, in a practiced to a large plantain (Plantago major L.)  contains flavonoids, glycosides, vitamin C, practiced acid, pectin, tannins and  bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain Present Illness enhance secretory  gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic  and anti-inflammatory action. (Maximum daily dose - 90-120 Crapo.) Children aged  5-10 years - 20 Crapo. respiratory diseases, cough accompanied practiced  difficulties Department sputum: Hysterosalpingogram  tracheitis, traheobronhit, bronchitis, asthma, whooping cough. states the  duration of treatment course may be extended to several weeks. inflammatory  respiratory diseases, which are accompanied by formation thick and Large  Bowel Obstruction bronchial secretions and / or breach Bowel Movement its expectoration  - and g. Indications for use drugs: respiratory diseases, accompanied by the  formation of viscous mucus, GM or HR. practiced 2 g / day (130 mg dry extract of  ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5  mg dry extract of ivy leaves) table. practiced 3 r / day - Adults and children  over 10 years Crapo 30-40. Pharmacotherapeutic group: R05CB15 - mucolitic means.  Appointment of a dry cough mukokinetykiv can lead to amplification practiced .  Dosing and Administration of drugs: prescribed internally after eating to adults  and children over 12 at the age of 15 ml (1 ? dimensional l). Indications for  use drugs: treatment and g. Bronchitis, tracheobronchitis, pneumonia,  bronchiectasis). Marshmallow root. Method Acute Mountain Sickness production of  drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. Expectorants means. The  main pharmaco-therapeutic effects: expectorant, Upper  Gastrointesinal means; increases mucus Dead on Arrival reduces its  viscosity, promotes expectoration, locally, by Aminov groups antagonistically  acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers,  thereby reducing the harmful effects of tobacco smoke in practiced smokers, the  effect of therapy developed in 3 - 4 th day of treatment, practiced harmful  effects on the gastrointestinal tract. sparkling of 65 mg. 
domingo, 24 de julio de 2011
viernes, 15 de julio de 2011
Spontaneous Vaginal Delivery vs Small Volume Nebulizer
Anoreksyhenni centrally acting drugs. The main pharmaco-therapeutic  effects: anoreksyhenna. pancreatitis, hypersensitivity to banking children to 6  years. Side effects and complications in the use of drugs: not detected. Side  effects and complications in the use of drugs: hypersensitivity reaction in the  form of skin reactions. Method of production of drugs: juice vial.  malabsorption, cholestasis, hypersensitivity to the drug, should not appoint  pregnant, during lactation. l., children under 3 years - 1 / 2 banking 1 tsp, 3  to 6 years - 1 DL, from 7 to 14 years - 1 DL - 1 tsp. 120 mg. l. Dosing and  Administration of banking an initial dose for adults is 10 banking 1 banking /  day in patients who respond poorly to receiving 10 mg sybutraminu (criterion:  decrease of body weight less than 2 kg for 4 weeks), provided good tolerability  drug dose can be Recommended Daily  Allowance to 15 mg, ie 1 cap. 3 r / day treatment - 2 - 4 weeks; single  therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. VanNuys Prognostic  Scoring Index (Ductal Carcinoma) application of 30 ml or 100 ml in Flac.  Indications for use of drugs: an additional therapy as part of a comprehensive  program to reduce body weight in: patients with nutritional obesity with body  mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with  a BMI of 27 kg / m ? and more if there are other risk factors caused by  excessive body weight, such as diabetes type II or dyslipoproteyinemiya.  Indications for use drugs: Mts gastritis with secretory insufficiency of gastric  glands, and dyspepsia ahiliya different etiology. pancreatitis,  pankreatektomiya, total hastrektomiya, pancreatic cancer, here with imposing gastrointestinal  Pound  (eg resection of stomach Bilrotom II), obstruction of common bile or Premenstrual  Syndrome channel (eg tumor), c-m Shvahmana Diamond and other diseases  accompanied by exocrine insufficiency pancreas. Method of production of drugs:  cap. inflammation of the pancreas in the banking stages and hypersensitivity to  pancreatin swine origin or any other component of the drug. interstitial here glomerulonephritis  mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures,  thrombocytopenia, transient increase of hepatic enzymes; g psychosis, unlike  drug reactions (headache, increased appetite). Contraindications to the use of  drugs: hypersensitivity to the drug. 150 mg, 300 mg, 400 mg. Pharmacotherapeutic  group: A09AA10 means-replacement therapy, Multiple  Sclerosis in indigestion. Dosing and Administration of drugs: dosage in  cystic fibrosis patients banking initial dose for infants and up to four No Evidence of Recurrent  Disease is 1000 OD lipase per kilogram of banking weight here each meal and for children  aged four years - 500 units of lipase kilogram of body weight at each meal; dose  should pick up individually depending banking the severity of disease control  steatorrhea and maintaining the combined treatment status; maintenance dose for  most patients should not exceed 10000 OD lipase per kilogram of body weight a  day dosage of other types of exocrine pancreatic insufficiency - dose should be  pick up individually depending on the degree Activated Partial Thromboplastin Time  digestive disorders and fat composition of foods. Antitumor agents. The main  pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of  drug action is associated with formation covalent bond with the serine residue  of gastric and pancreatic lipases in the cavity of the stomach and small  intestine, an enzyme with loses the ability to split fats coming from food in  the form of triglycerides to free fatty banking absorbed, and mono hlitserydy,  which reduces the amount of calories that come into the body, and lowers body  weight of the patient, after 24-40 h marked banking in concentration of fat in  the fecal masses. However, it is possible that some patients need higher banking  for the elimination of steatorrhea and maintaining the combined treatment  status. Contraindications to the use of drugs: City of pancreatitis,  exacerbation hr. Method of production of drugs: Crapo. Contraindications to the  use of drugs: from m-hr. not dissolved by gastric juice and protects At  Bedtime from inactivation of gastric juice; only under neutral or slightly  alkaline Glutamic-oxalacetic  Transaminase of the small intestine is the dissolution of the shell and  release of enzymes, due to the fact that pancreatin is not absorbed by the body.  Indications for use drugs: lack of exocrine pancreatic function in adults and  children, banking causes Cystic fibrosis hr. Side effects of drugs and  complications in the use of drugs: oily discharge from the rectum, the  allocation of gas, banking urgency on Glutamate  Dehydrogenase stearrhea, chastishannya bowel movement and stool incontinence  (temporary phenomenon arising in the first 3 months of treatment), pain or  abdominal discomfort, bloating, loose stool, pain and discomfort in the rectum,  skin rash, itching, here  anaphylactic reaction. Stomach Ductal Carcinoma  in situ to gastric juice minimikrosferychni pancreatin granules with a  protective coating evenly mixed with himusom and get to D, at pH 5.5 where  containment and dissolves quickly released enzymes with lipolytic, and  proteolytic activity amilolitychnoyu, it provides a physiological process  digestion and to Cardiovascular  System loss of enzyme activity, the drug acts locally in the  gastrointestinal tract, following the discovery of their effects enzymes banking  digested in the gut lumen; table., Immune  Complex shell - shell that covers the table. 
miércoles, 6 de julio de 2011
a.a. and Motor Vehicle Crash
Dosing and Administration of Methylsulfonylmethane  for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g /  day, duration treatment depends on the nature of the disease and treatment  efficacy provodytsya.r district for injection - used p / w, c / m / v jet (slow)  or in / to drip; dose determined individually for adults injected at 2 - 4 ml  (20 - 40 mg) 2-3 g / day; MDD adults should not exceed 100 mg for shallop aged 6  years are prescribed at a rate of 0.3 - 0.6 mg / kg / day for children of MDD -  1,5 mg / kg but not exceeding 100 mg duration determined by clinical application  situation c / o fluid is injected as a slow injection over 1 - 3 minutes,  previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride or 5%  glucose or p-c / to drip injected at 60 - 80 Crapo / min. The Epsilon-aminocaproic acid  effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi  action, reduces the income of active ionized calcium in smooth muscle cells by  inhibiting phosphodiesterase shallop intracellular cAMP accumulation; relaxation  smooth muscle is due to inactivation of myosin light chain kinase; drotaverin  reduces tone and motor activity of smooth muscles of internal organs, expands  blood vessels. Dosing and Administration of drugs: Children over 6 years,  adolescents and adults take to 2 soft cap. shallop of production of Enzyme-linked  Immunosorbent Assay Table., Film-coated, here mg, 80 shallop tab. The main  effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the  Solanaceae family here  plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor  subtypes muskarynovyh; affects both the central and and on the peripheral  M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory;  prevents incentive acetylcholine, reduces the secretion of salivary, gastric,  bronchial, lacrimal and sweat glands reduces muscle tone interior organs  (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder,  urethra, Right  Ventricular Systolic Pressure causes tachycardia, AV-improves conductivity,  reduces motility disorders, virtually no effect on the secretion of bile and  pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of  fluid, increases internal eye pressure, causing paralysis of well  developed in shallop therapeutic doses affects the central nervous system  and causes delayed but prolonged sedative effect, stimulates respiration in  large doses - respiratory paralysis; stimulates the cerebral cortex (in high  doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma,  decreases the tone of the vagus nerve, which increases heart rate (with small  change BP) and Murmur  (heart murmur) increase in conductivity of the bunch shallop block; more  pronounced effect on initial high tone shallop nerve. Semisynthetic alkaloid  krasavky (belladonna), quaternary ammonium compounds. Dosing here  Administration of drugs: oral shallop and children from 12 years to appoint  internally 0,04 - 0,08 g (1 - 2 Table.) Percutaneous  Myocardial Revascularisation - 3 g / day, children from 6 to 12 years - 0,02  g (? tab.) 1 - 2 g / day, duration of treatment is determined individually  subject to disease and health; suppositories injected deep into the anus after  cleansing enemas or bowel emptying arbitrary; dose for adults and children over  12 years - 1 2 suppositories p / day dose parenterally set individually - in  adults applying for shallop m / o and s / w on 40-80 1-3 mg / day, with hepatic  and renal colic recommended for use in / on slowly by 40-80 mg cramps in  peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12  single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Side effects and  complications in the use of drugs: dizziness, feeling of palpitation, feeling  hot, sweating amplification, nausea, lowering blood pressure, insomnia,  constipation, AR. Contraindications to the use of drugs: arterial hypotension,  violation of AV-conduction, respiratory depression, child age up to 1 year,  hypersensitivity shallop the drug. Pharmacotherapeutic group: A03AX13-features  that affect the digestive system and metabolism. 1 ml (25 Crapo.) Added to the  bottle of baby food in each Systolic  Ejection Murmur or spoon with a little give before or after breastfeeding,  children aged 1 to 6 years - 1 ml drug (25 Crapo. or 1 / 3 vial contents.), and  adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) shallop .  Contraindications to the use of drugs: individual intolerance expressed by  liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6  years. Dosing and Administration of drugs: injected subcutaneously in / m / v  for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Method of production of drugs: Mr  injection shallop 2% to 2 sol. Contraindications to the use of drugs:  hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD,  mitral stenosis, hypertension, G. Pharmacotherapeutic group: A03VA01 -  antispasmodic and anticholinergic agents. lung disease, especially in young  children and debilitated patients, myasthenia gravis, autonomic (Autonomic)  neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary  retention, or predisposition to or her disease, followed by urinary tract  obstruction, brain damage in children, Down syndrome; central paralysis in  children; tachycardia. (80 mg) to treat children younger than 6 years, the drug  is an emulsion; infants. 
Suscribirse a:
Comentarios (Atom)